Brief: Unity Biotechnology Q1 Operating Income USD -6.891 Million
22/04/2025 21:30
Apr 22 (Reuters) - Unity Biotechnology Q1 operating expenses USD 6.891 million. Q1 basic EPS USD -0.43 Q1 net income USD -7.302 million
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force